Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.
| Revenue (TTM) | $50.51M |
| Gross Profit (TTM) | $38.04M |
| EBITDA | $-30.29M |
| Operating Margin | -61.40% |
| Return on Equity | -47.60% |
| Return on Assets | -21.00% |
| Revenue/Share (TTM) | $3.55 |
| Book Value | $3.72 |
| Price-to-Book | 2.63 |
| Price-to-Sales (TTM) | 5.14 |
| EV/Revenue | 3.321 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 61.20% |
| Shares Outstanding | $26.73M |
| Float | $9.46M |
| % Insiders | 43.55% |
| % Institutions | 38.67% |
Volatility is currently contracting